Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
01.09.2022 17:16:46

DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year

DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Raising forecast for the current fiscal year

01-Sep-2022 / 17:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Bremen, September 1, 2022 MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development:

  • For fiscal year 2021/2022 (October 1, 2021 to September 30, 2022), revenues are now expected to increase significantly to 17.5 million to 18.0 million (previous forecast for fiscal year 2021/2022: stable revenues of 16.0 million to 16.5 million).
  • For EBIT (earnings before interest and taxes), the forecast for fiscal year 2021/2022 (October 1, 2021 to September 30, 2022) is now expected to increase significantly to 6.0 million to 6.5 million (previous forecast for fiscal year 2021/2022: stable EBIT of 4.0 million to 4.5 million).

Reasons for the increased revenues are the positive business development with the customer Hologic both in the license and in the maintenance business and, in addition, the development services with various medical technology companies have also developed very positively.

 

Contact:

Kirchhoff, Marcus / CEO

01-Sep-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: https://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1433695

 
End of Announcement DGAP News Service

1433695  01-Sep-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1433695&application_name=news&site_id=smarthouse

Analysen zu MeVis Medical Solutions AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

MeVis Medical Solutions AG 24,00 -2,44% MeVis Medical Solutions AG